AbbVie 8-K
Debt financing
Completed a seven-tranche unsecured senior-note offering, combining floating- and fixed-rate debt with maturities extending to 2066.
Filed 2026-03-04 16:59 ET
- 8.01 Other Events
- 9.01 Financial Statements and Exhibits
Summary
Completed a $8.0B aggregate-principal public debt offering across seven senior-note tranches. The notes are unsecured and unsubordinated, ranking equally with AbbVie’s existing and future unsecured, unsubordinated obligations.
Key Figures
- $0.75B floating-rate notes due 03/03/2028; coupon is floating.
- Fixed-rate notes: $1.5B at 3.775% due 03/03/2028; $1.25B at 4.125% due 03/15/2031; $1.25B at 4.400% due 03/15/2033; $1.5B at 4.750% due 03/15/2036; $1.25B at 5.550% due 03/15/2056; and $0.5B at 5.650% due 03/15/2066.
- Fixed-rate notes may be redeemed before their applicable par-call dates at make-whole prices; after those dates, the notes other than the 2028 notes may be redeemed at 100% of principal plus accrued interest.
The summary is written by an AI model reading the filing.
Model 005 · prompt 01d34d48e3